328 related articles for article (PubMed ID: 14532912)
1. Nociceptin/orphanin FQ increases anxiety-related behavior and circulating levels of corticosterone during neophobic tests of anxiety.
Fernandez F; Misilmeri MA; Felger JC; Devine DP
Neuropsychopharmacology; 2004 Jan; 29(1):59-71. PubMed ID: 14532912
[TBL] [Abstract][Full Text] [Related]
2. Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats.
Vitale G; Arletti R; Ruggieri V; Cifani C; Massi M
Peptides; 2006 Sep; 27(9):2193-200. PubMed ID: 16730097
[TBL] [Abstract][Full Text] [Related]
3. Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation.
Green MK; Barbieri EV; Brown BD; Chen KW; Devine DP
Neuropeptides; 2007 Dec; 41(6):399-410. PubMed ID: 17980908
[TBL] [Abstract][Full Text] [Related]
4. GABA(A) signalling is involved in N/OFQ anxiolytic-like effects but not in nocistatin anxiogenic-like action as evaluated in the mouse elevated plus maze.
Gavioli EC; Duarte FS; Guerrini R; Calo G; Rae GA; M De Lima TC
Peptides; 2008 Aug; 29(8):1404-12. PubMed ID: 18499303
[TBL] [Abstract][Full Text] [Related]
5. Nociceptin/orphanin FQ regulates neuroendocrine function of the limbic-hypothalamic-pituitary-adrenal axis.
Devine DP; Watson SJ; Akil H
Neuroscience; 2001; 102(3):541-53. PubMed ID: 11226692
[TBL] [Abstract][Full Text] [Related]
6. Functional antagonism between nociceptin/orphanin FQ and corticotropin-releasing factor in rat anxiety-related behaviors: involvement of the serotonergic system.
Filaferro M; Ruggieri V; Novi C; Calò G; Cifani C; Micioni Di Bonaventura MV; Sandrini M; Vitale G
Neuropeptides; 2014 Aug; 48(4):189-97. PubMed ID: 24894718
[TBL] [Abstract][Full Text] [Related]
7. Modification of anxiety-like behaviors by nociceptin/orphanin FQ (N/OFQ) and time-dependent changes in N/OFQ-NOP gene expression following ethanol withdrawal.
Aujla H; Cannarsa R; Romualdi P; Ciccocioppo R; Martin-Fardon R; Weiss F
Addict Biol; 2013 May; 18(3):467-79. PubMed ID: 22804785
[TBL] [Abstract][Full Text] [Related]
8. Low-dose Nociceptin/Orphanin FQ reduces anxiety-like performance in alcohol-withdrawn, but not alcohol-naïve, Male Wistar rats.
Aujla H; Nedjadrasul D
Neuropharmacology; 2015 Jun; 93():1-6. PubMed ID: 25617519
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the GABA/benzodiazepine receptor in the axiolytic-like effect of nociceptin/orphanin FQ.
Uchiyama H; Yamaguchi T; Toda A; Hiranita T; Watanabe S; Eyanagi R
Eur J Pharmacol; 2008 Aug; 590(1-3):185-9. PubMed ID: 18586237
[TBL] [Abstract][Full Text] [Related]
10. Role of amygdaloid nuclei in the anxiolytic-like effect of nociceptin/orphanin FQ in rats.
Uchiyama H; Toda A; Hiranita T; Watanabe S; Eyanagi R
Neurosci Lett; 2008 Jan; 431(1):66-70. PubMed ID: 18166271
[TBL] [Abstract][Full Text] [Related]
11. Nociceptin/orphanin FQ content is decreased in forebrain neurones during acute stress.
Devine DP; Hoversten MT; Ueda Y; Akil H
J Neuroendocrinol; 2003 Jan; 15(1):69-74. PubMed ID: 12535171
[TBL] [Abstract][Full Text] [Related]
12. Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity.
Walf AA; Frye CA
Neuropsychopharmacology; 2005 Jul; 30(7):1288-301. PubMed ID: 15756306
[TBL] [Abstract][Full Text] [Related]
13. Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test.
Gavioli EC; Rae GA; Calo' G; Guerrini R; De Lima TC
Br J Pharmacol; 2002 Jul; 136(5):764-72. PubMed ID: 12086986
[TBL] [Abstract][Full Text] [Related]
14. Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress.
Jenck F; Moreau JL; Martin JR; Kilpatrick GJ; Reinscheid RK; Monsma FJ; Nothacker HP; Civelli O
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14854-8. PubMed ID: 9405703
[TBL] [Abstract][Full Text] [Related]
15. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.
Varty GB; Morgan CA; Cohen-Williams ME; Coffin VL; Carey GJ
Neuropsychopharmacology; 2002 Sep; 27(3):357-70. PubMed ID: 12225693
[TBL] [Abstract][Full Text] [Related]
16. Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task.
Asth L; Correia N; Lobão-Soares B; De Lima TC; Guerrini R; Calo' G; Soares-Rachetti VP; Gavioli EC
Naunyn Schmiedebergs Arch Pharmacol; 2015 Jan; 388(1):33-41. PubMed ID: 25319847
[TBL] [Abstract][Full Text] [Related]
17. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm.
Leggett JD; Jessop DS; Fulford AJ
Neuroscience; 2007 Jul; 147(3):757-64. PubMed ID: 17574767
[TBL] [Abstract][Full Text] [Related]
18. Nociceptin/orphanin FQ and related peptides reduce the increase in plasma corticosterone elicited in mice by an intracerebroventricular injection.
Le Cudennec C; Naudin B; Do Rego JC; Costentin J
Life Sci; 2002 Nov; 72(2):163-71. PubMed ID: 12417250
[TBL] [Abstract][Full Text] [Related]
19. The voltage-gated sodium channel activator veratrine induces anxiogenic-like behaviors in rats.
Saitoh A; Makino Y; Hashimoto T; Yamada M; Gotoh L; Sugiyama A; Ohashi M; Tsukagoshi M; Oka J; Yamada M
Behav Brain Res; 2015 Oct; 292():316-22. PubMed ID: 26099814
[TBL] [Abstract][Full Text] [Related]
20. Nociceptin/orphanin FQ-induced delay in gastric emptying: role of central corticotropin-releasing factor and glucocorticoid receptors.
Broccardo M; Scaccianoce S; Del Bianco P; Agostini S; Petrella C; Improta G
Neurogastroenterol Motil; 2005 Dec; 17(6):871-7. PubMed ID: 16336503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
